Even a patient with BRAF-mutated malignant melanoma has a chance for long-term survival

نویسندگان

چکیده

Maligní melanom patří k agresivním nádorům se stoupající incidencí a přesunem výskytu do mladších věkových kategorií. Při metastazování léta patřil diagnóze s velice rychlou infaustní prognózou (1). Ani onkologické léčebné postupy (chemoterapie) nedokázaly prodloužit medián přežití o více než 6-9 měsíců. Objevení mutace BRAF V600 v r. 2002 bylo průlomem pochopení etiologie maligního melanomu. V případě kožního melanomu je prokázana u 40-60 % všech případů signalizuje horší prognózu pacienta (2).

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Improved survival with MEK inhibition in BRAF-mutated melanoma.

BACKGROUND Activating mutations in serine-threonine protein kinase B-RAF (BRAF) are found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy improves survival, as compared with chemotherapy, but responses are often short-lived. In previous trials, MEK inhibition appeared to be promising in this population. METHODS In this phase 3 open-label trial, we randomly assigned...

متن کامل

Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment

Treatment responses of BRAF mutant melanoma to BRAF inhibitors are often limited by the development of resistance. This case report describes the use of multiplatform molecular profiling in sequential surgical samples of a treatment-resistant tumour site subjected to ongoing treatment with dabrafenib in a patient with metastatic cutaneous BRAF mutant melanoma. Next-generation sequencing showed ...

متن کامل

Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation.

Introduction. BRAF kinase inhibitors such as Vemurafenib have shown improvement in overall survival, progression-free survival, and response rates in patients with metastatic melanoma with BRAF V600K mutation. However, there were no cases of complete remission reported in patients with V600K mutation before. Case Presentation. A 53-year-old man with metastatic melanoma and dialysis dependent en...

متن کامل

A Chance Constrained Integer Programming Model for Open Pit Long-Term Production Planning

The mine production planning defines a sequence of block extraction to obtain the highest NPV under a number of constraints. Mathematical programming has become a widespread approach to optimize production planning, for open pit mines since the 1960s. However, the previous and existing models are found to be limited in their ability to explicitly incorporate the ore grade uncertainty into the p...

متن کامل

Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanoma

The BRAF inhibitor, vemurafenib, has demonstrated improved progression-free and overall survival compared with chemotherapy in a randomized trial, and represents a new standard of care in patients with advanced melanoma harboring a BRAF-V600 mutation. A BRAF-V600 mutation is identified in approximately half of patients with cutaneous melanoma, and is unequivocally a biomarker predictive of prof...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Onkologie

سال: 2021

ISSN: ['1803-5345', '1802-4475']

DOI: https://doi.org/10.36290/xon.2021.008